Wells Fargo
RNXT icon

Wells Fargo’s RenovoRx RNXT Stock Holding History

Wells Fargo’s Portfolio RNXT Stock Details RNXT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-69
Closed -$92 – 7369
2024
Q1 		$92 Buy
69
+2
+3% +$3 ﹤0.01% 6683
2023
Q4 		$153 Buy
67
+6
+10% +$6 ﹤0.01% 6665
2023
Q3 		$81 Buy
61
+12
+24% +$22 ﹤0.01% 6819
2023
Q2 		$111 Buy
49
+7
+17% +$17 ﹤0.01% 6846
2023
Q1 		$146 Buy
42
+1
+2% +$4 ﹤0.01% 6848
2022
Q4 		$96 Buy
41
+1
+3% +$2 ﹤0.01% 6806
2022
Q3 		$0 Buy
40
+24
+150% +$52 ﹤0.01% 7243
2022
Q2 		$0 Buy
16
+1
+7% +$2 ﹤0.01% 7368
2022
Q1 		$0 Buy
15
+4
+36% +$14 ﹤0.01% 7685
2021
Q4 		$0 Buy
+11
New +$65 ﹤0.01% 7706

Other funds holding RNXT

ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NPT
Nixon Peabody Trust Boston, Massachusetts $1.41B AUM 27.78% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACA
Affinity Capital Advisors Berkeley, California $810M AUM 24.85% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Wells Fargo's RNXT Position: Q2 2024 in Review

Wells Fargo sold out of RenovoRx (RNXT) in Q2 2024, closing a stake of 69 shares — an estimated $92 sold.

Wells Fargo first reported a position in RNXT in Q4 2021 and held it in 10 quarters. The position peaked at $153 in Q4 2023. 17 funds tracked by Wall St. Rank hold RNXT as of Q2 2024.

  • Wells Fargo reported no remaining RenovoRx position as of Q2 2024 after selling out during the quarter.
  • Wells Fargo sold 69 RenovoRx shares in Q2 2024, an estimated $92.
  • Wells Fargo first reported a position in RenovoRx in Q4 2021 and held it in 10 quarters.
  • Wells Fargo's RenovoRx position peaked at $153 in Q4 2023.
  • 17 funds tracked by Wall St. Rank held RenovoRx as of Q2 2024.

Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.